搜尋優化
Rewards
English
हिंदी
বাংলা
اردو
ਪੰਜਾਬੀ
मराठी
తెలుగు
தமிழ்
ಕನ್ನಡ
ગુજરાતી
മലയാളം
ଓଡ଼ିଆ
搜尋
Copilot
圖片
影片
地圖
新聞
購物
更多
航班
旅遊
旅館
不動產
我的 Bing
筆記本
Top stories
India
World
Entertainment
Sci/Tech
Business
Politics
Sports
Lifestyle
Bing 上的熱門主題
PM Modi's Swearing-in Ceremony: Check List Of Top World Leaders Invited For Oath-Taking
Why BJP failed to get Ayodhya's blessings despite Ram Mandir
Stocks to buy or sell: KNR Constructions to ABFRL — Sumeet Bagadia recommends five breakout stocks today
'Muslims Prefer... ': Assam CM Himanta After NDA Loss In 3 Assam Seats
Modi 3.0 Cabinet: BJP draws red line as allies aim for big portfolios
Immediate impact: This new Indian SUV starts by beating Venue, Sonet. Only behind Brezza, Nexon
Army chief to ED boss .... big appointments waiting for new government
Why INDI Alliance has chosen to sit in the Opposition benches in Parliament
'Please do not confine me to...': What Suresh Gopi, BJP's first MP from Kerala, expects after historic Lok Sabha win
Fielding medal returns as team India welcome special guest to handover the award
Lok Sabha Election results 2024: Why Modi 3.0 coalition govt is good news for India. Yogendra Yadav explains
Sabse Achchhi Party: Meerut Underdog That Won Hearts During Lok Sabha Elections
Heavy rainfall in these states over next 5 days as monsoon advances: IMD updates
ICC T20 World Cup 2024: USA Script History With Super Over Win Against Pakistan in Huge Upset
Right Foot Forward | Not Your Victory: Why Congress Should Not Celebrate Lok Sabha Results
'AAP To Go Solo In Delhi Election': Gopal Rai Rules Out Alliance With Congress For 2025 Polls
Cabinet Berths On Cards: Shiv Sena, TDP Likely To Propose These Names Ahead Of Govt Formation
'He is Our Number 3': India Confirm Demotion for Suryakumar Yadav After Rishabh Pant's Sparkling Show in New York
‘The Culture’: Irfan Pathan’s Big Praise After Pat Cummins Carries Drinks in Australia’s World Cup Match Against Oman
Just 6 Lakh Votes In 32 Seats Could Have Earned BJP A Majority On Its Own, But Razor-Thin Losses Spoiled The Party
EPFO Introduced These Major Changes To EPF Rules; Know Key Changes
6 Names in Race to Be BJP's First Odisha CM, And Then There Are The Underdogs
2 Sena MPs, 1 Maratha Leader, Piyush Goyal & Nitin Gadkari? A Look at Maharashtra's Combo in Cabinet Race
Sharvari Wagh On Working With Sathyaraj AKA Baahubali's Katappa: 'It's Like Attending Acting Workshop'
Sanjiv Bhasin Penny Stock: Share price Rs 15 and target Rs 25
日期
過去 1 小時
過去 24 小時
過去 7 天
過去 30 天
最符合項目
最近的新聞
9 天
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment
The U.S. Food and Drug Administration approved on Tuesday Amgen's Bkemv, the first biosimilar to AstraZeneca's rare blood ...
Drug Store News
2 天
FDA approves Amgen's Soliris biosimilar
Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. The treatment of patients ...
1 天
Amgen Seeks Expanded US Approval For Autoimmune Disease Drug Acquired Via $28B Horizon Deal
Amgen Inc (NASDAQ:AMGN) announced topline results from its Phase 3 trial evaluating the efficacy and safety of Uplizna ...
FiercePharma
8 天
Amgen grabs FDA thumbs-up for Soliris biosim, eyes 2025 launch
Amgen has made waves in the biosimilar field in recent years with its U.S.-first Humira biosim launch last year and its ...
pharmaphorum
15 小時
Amgen preps Uplizna filing for a second indication
Uplizna also hit the target on a number of secondary measures, including: annualised flare rate; flare-free, treatment-free ...
1 天
on MSN
Amgen posts late-stage win for Uplizna in immune-mediated disorder
Uplizna therapy reaches main goal in Phase 3 trial for IgG4-RD, cutting the risk of flare by 87% with no new safety events.
FiercePharma
1 天
Amgen's Uplizna proves its worth in another rare disease, setting up regulatory filings in US and beyond
The CD19-targeted rare disease medicine Uplizna was one of the crown jewels in Amgen’s $27.8 billion buyout of Horizon ...
6 天
on MSN
Should you buy Amgen’s stock above $300?
Amgen Inc. (NASDAQ:AMGN) has recently been in the news due to its involvement in the promising obesity drug market. Analysts ...
Managed Healthcare Executive
3 天
FDA Updates for Week of May 27: 2 Approvals including New Biosimilar
The FDA has made two approvals this week: the first interchangeable biosimilar of Soliris and another indication for Breyanzi ...
The Financial Express on MSN
7 天
USFDA gives nod to first interchangeable biosimilar for two rare diseases
Interestingly, Bkemv is the 53rd approved biosimilar in the U.S. The FDA has approved 13 of these as interchangeable ...
8 天
Could weight-loss drugs eat the world?
So far only three GLP-1 drugs have been approved to treat obese or overweight individuals: liraglutide and semaglutide, ...
某些結果已隱藏,因為您可能無法存取這些結果。
顯示無法存取的結果
意見反應